Market access barriers and market value in Mexican public sector for biosimilars
hospitals. The total pharma market value is worth over 4,500 MUSD per year, and 1,750 million units. Also, will explain the access roadmap
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
hospitals. The total pharma market value is worth over 4,500 MUSD per year, and 1,750 million units. Also, will explain the access roadmap
available on the market but the bigger issue for a multisource market is that the promise of increased access for patients is not currently being realized. This presentation will review
The purpose of this study is to describe the evolution of convergence
Biotechnological medicines are medicinal products of biotechnological origin that contain proteins derived
Market Access (MA) term was first introduced by the World Trade Organization (WTO) to define the competing relation between the domestic and the imported products of a country ... agreed by WTO members for the entry of…
stage econometric method was used to investigate the contribution of market access and other micro-level factors in facilitating crop intensification and productivity. Ethiopia is the leading commercial producer…
effectively balance pricing expectations with clinical profile and uptake potential to optimize market access. On the other hand, EU5 healthcare agencies must find ways to manage their ever-tightening budgets ... spinal…
New Zealand is the largest exporter of lamb and beef in the
Biotechnological medicines are medicinal products of biotechnological origin that contain proteins derived
âÂ?¢ Understand the type of FDA approval (abbreviated versus full stop BLA
• Understand the type of FDA approval (abbreviated versus full stop BLA) impacting
there needs to be a reaffirmation and fine balance between the tenacities of gaining market access of pharmaceuticals is to protect the public health and facilitate healthy growth of pharmaceutical
such as supplementary protection certificates, data and marketing exclusivity. The reasons for delay of market access for generic medicines in Europe are their regulatory frame work, pricing and reimbursement ... upon…
identification and assessment of farmer’s personal attributes influencing farmerto-farmer dissemination of market access and technology information. A baseline survey, preceding a participatory value chain analysis…
under cost-effectiveness analysis. The aim of this study is the evaluation of the Market-Access Agreement in the European and USA pharmaceutical market as a harmonization process between pharma ... will compare the…
Outcomes-based agreements, which ensure that drug companies are paid for actual
potential in growth and of becoming Ghana’s leading non-traditional export. Export market accessibility by small-scale mango farmers in Southern Ghana is low and this could stem from ... employed to analyze the…
Statement of the Problem: It is difficult and expensive to meet the
This study aimed at analyzing socio-economic factors influencing accessibility to market information among smallholder spice farmers in Tanzania, a case of Morogoro district. The study adopted a cross-sectional…
test the hypothesis that the access of smallholder pineapple farmers to information reduces the costs of doing business, increases income and hence increases market linkage in Benin. Evidence showed that ... money which…
The Chabahar port is set to become a trading hub that will
stage process) show that ownership of assets such as radios and having access to alternative marketing channels increased the likelihood of market participation while the heckit results (OLS corrected ... increased…
For authors and organisers
Find the right journal for your paper and submit your manuscript.